Clinical reserch of the efficacy of Adipose derived stem cell for liver cirrhosis - ADSC-LC

Itano Satoshi0 个研究点目标入组 6 人开始时间: 2020年4月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Inclusion criteria
•1.Clinically diagnosed as cirrhosis by CT and blood tests.
•2.Child-Pugh score must be 6 points or more.
•3.Must be between 20 and 90 years old.
•4.Prior written consent to participate in the study must be obtained in writing.

•Exclusion criteria
•A. Patients whose abstinence cannot be expected during the treatment period
•B. Patients with severe heart disease (obvious heart failure and arrhythmia)
•C. Patients with hypersensitivity to the anesthetic used when collecting adipose tissue
•D. Patients with uncontrolled malignant or intraepithelial neoplasia
•E. Patients with uncontrollable infections
•F. Pregnant women, lactating and possibly pregnant
•G. Patients taking birth control pills
•H. Patients who cannot give their informed consent
•I. Patients who cannot evaluate the efficacy
•J. Patients who can undergo other effective treatments, liver transplantation (living body and brain death)
•K. Other patients who are judged to be inappropriate by the investigator.

发起方

Itano Satoshi